It was an extraordinary week for children’s hospitals in the UK.
On Monday, the Royal Free Children’s Hospital in London was officially declared a “specialised” children’s cancer hospital by the UK’s National Institute for Health and Care Excellence (Nice).
On Tuesday, the Children’s Hospitals of South Wales (CHOS) and the Royal Children’s Medical Research Institute (RCMI) announced that they would be opening their own specialist brain tumours centres.
On Wednesday, the first British children’s brain tumouring centre opened in Glasgow.
And on Thursday, the UK Health Secretary Jeremy Hunt announced that all UK children’s centres would now have a new brain-tumour specialist to help them deal with the growing number of children who are undergoing brain surgery.
But in this case, the story of a hospital in Wales is more complex.
The Royal Free children’s Hospital and CHOS, near Cardiff, are both part of a cluster of hospitals that have operated for decades as a joint venture between the NHS and GPs.
The hospitals were founded in 1891 by a young physician named Dr John O’Leary.
O’Lea was a surgeon, and the hospital was a hospital for doctors and surgeons.
In the late 19th century, O’Lavers work in England became more focused on the treatment of small tumours.
In the 20th century and the 20s, OA’s hospital work moved into larger, more complex operations.
By the time he died in 1991, OLA had expanded to a 400-bed hospital in Cardiff and was the only one of O’Ales experiments in the United Kingdom to operate on a brain-cancer patient.
It was a landmark achievement.
OA and his wife, Dr Frances O’Reilly, were awarded a Nobel Prize in physiology or medicine in 1953 for developing techniques for treating brain tumous tissue.
The hospital was the first in Wales to have a dedicated brain-research centre.
But it soon realised that it could no longer keep up with the increasing demand for its services.
The NHS was struggling to cope with an unprecedented number of new patients, and O’Loans health plans were in tatters.
It was a time of rapid expansion and transformation in British medicine.
By 1955, it had about 15,000 patients per year, but only 5,000 of them were undergoing treatment.
As the economy began to recover, the hospitals became more and more dependent on the NHS for their operations.
The financial crisis of the early 1990s and the recession that followed led to the closure of most of the GPs in the hospital.
By 2008, it was down to just over 6,000.
When I asked Dr O’Elliott if he thought the new brain centre would attract new patients or provide jobs, he said: “I don’t think it will.
It will only bring in a small number of people.”
It is a worrying sign for the NHS in Wales.
In England, the number of brain tumoured children has doubled in the last 10 years, to 1.6 million.
In Wales, the figure is 2.1 million.
But Dr OElliots work on the Royal Infirmary of Wales, at Cardiff’s Royal Infill, is part of the same cluster.
So, it is not just the number that matters, but the nature of the treatment.
There is an urgent need for a dedicated specialist in the field of brain-transplantation.
There is little information on the long-term effects of brain surgery on the brain.
The research is limited, and there is little evidence that surgery alters the structure or function of the brain, although there is some evidence that it can reduce levels of inflammation.
The Royal Infil, as the hospital is called, is a complex medical unit, and Dr OOllys work is in a part of it that is not connected to the rest of the hospital, where there are also radiotherapy units, which are used to treat other brain tumorous patients.
The surgery takes place in a specially equipped, open-air chamber with a ventilator.
There are six radiologists working on each patient.
One radiologist will be there for the first 15 minutes and then shift to another patient.
The next radiologist works on the next patient, and so on until the patient is dead.
It is an intensive process that can take a couple of hours.
Dr OEllys patients are given their own treatment and then transferred to a different patient in the same ward for further treatment.
In a hospital like the Royal Royal Infile, which is part-funded by the NHS, the money to pay for the surgery is provided by the taxpayer.
But the funding has come under pressure in recent years.
In 2015, the Government decided to scrap the so-called “reimbursement charge”, which had been introduced in 2012 to make sure that hospitals were not spending too much money on the surgery of patients who had already had brain surgery